1. Home
  2. GNLX vs INVE Comparison

GNLX vs INVE Comparison

Compare GNLX & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • INVE
  • Stock Information
  • Founded
  • GNLX 2001
  • INVE 1990
  • Country
  • GNLX United States
  • INVE United States
  • Employees
  • GNLX N/A
  • INVE N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • INVE Computer peripheral equipment
  • Sector
  • GNLX Health Care
  • INVE Technology
  • Exchange
  • GNLX Nasdaq
  • INVE Nasdaq
  • Market Cap
  • GNLX 128.0M
  • INVE 85.9M
  • IPO Year
  • GNLX 2023
  • INVE 1997
  • Fundamental
  • Price
  • GNLX $3.91
  • INVE $3.66
  • Analyst Decision
  • GNLX Strong Buy
  • INVE Strong Buy
  • Analyst Count
  • GNLX 4
  • INVE 2
  • Target Price
  • GNLX $17.75
  • INVE $5.50
  • AVG Volume (30 Days)
  • GNLX 151.7K
  • INVE 37.8K
  • Earning Date
  • GNLX 11-13-2025
  • INVE 11-06-2025
  • Dividend Yield
  • GNLX N/A
  • INVE N/A
  • EPS Growth
  • GNLX N/A
  • INVE N/A
  • EPS
  • GNLX N/A
  • INVE 3.12
  • Revenue
  • GNLX N/A
  • INVE $23,538,000.00
  • Revenue This Year
  • GNLX N/A
  • INVE N/A
  • Revenue Next Year
  • GNLX N/A
  • INVE $9.98
  • P/E Ratio
  • GNLX N/A
  • INVE $1.19
  • Revenue Growth
  • GNLX N/A
  • INVE N/A
  • 52 Week Low
  • GNLX $1.95
  • INVE $2.86
  • 52 Week High
  • GNLX $5.89
  • INVE $4.29
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 59.55
  • INVE 49.91
  • Support Level
  • GNLX $3.76
  • INVE $3.58
  • Resistance Level
  • GNLX $3.61
  • INVE $3.85
  • Average True Range (ATR)
  • GNLX 0.25
  • INVE 0.14
  • MACD
  • GNLX 0.05
  • INVE -0.02
  • Stochastic Oscillator
  • GNLX 67.03
  • INVE 25.00

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has one reportable segment: the IoT Business segment. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific.

Share on Social Networks: